Zensar has been recognized as a Major Contender in the Everest Group Life Sciences Digital Services PEAK Matrix® Assessment 2025.
“Amid rising R&D costs and regulatory complexities to accelerate product development and market access, life sciences enterprises are increasingly seeking and prioritizing AI-native, domain-centric digital investments that can deliver clear and measurable outcomes across the value chain, which is gaining further momentum with the advent of generative and agentic AI,” said Durga Ambati, Practice Director at Everest Group.
“Zensar’s acquisition of BridgeView Life Sciences to strengthen its capabilities in life sciences commercial space, its strategic partnerships with hyperscalers and technology vendors to co-innovate life sciences-specific AI solutions, and its differentiated focus to cater to the needs of small and mid-sized life sciences enterprises sets it apart from its peers. This has earned it a Major Contender position in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025.”